scholarly article | Q13442814 |
P356 | DOI | 10.1179/1351000215Y.0000000040 |
P698 | PubMed publication ID | 26321469 |
P50 | author | Fermín P Pacheco-Moises | Q59697717 |
Luis Miguel Román-Pintos | Q89458003 | ||
P2093 | author name string | Adolfo Daniel Rodríguez-Carrizalez | |
Alejandra Guillermina Miranda-Díaz | |||
Esaú César Martínez-Romero | |||
Guillermo Miller-Arrevillaga | |||
José Alberto Castellanos-González | |||
P2860 | cites work | Lipid peroxidation: pathophysiological and pharmacological implications in the eye | Q21129236 |
Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes | Q28241500 | ||
Biochemical functions of coenzyme Q10 | Q28611180 | ||
Heme oxygenase-1 protects retinal endothelial cells against high glucose- and oxidative/nitrosative stress-induced toxicity | Q31083347 | ||
Management of diabetic retinopathy: a systematic review | Q33294803 | ||
Inducible nitric oxide synthase isoform is a key mediator of leukostasis and blood-retinal barrier breakdown in diabetic retinopathy | Q33303988 | ||
Oxidants, antioxidants and mitochondrial function in non-proliferative diabetic retinopathy | Q34516437 | ||
Carotenoids and antioxidants in age-related maculopathy italian study: multifocal electroretinogram modifications after 1 year | Q34582050 | ||
Carotenoids in Age-related Maculopathy Italian Study (CARMIS): two-year results of a randomized study | Q34633116 | ||
Coenzyme Q10 in neuromuscular and neurodegenerative disorders | Q34659578 | ||
Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales | Q35226427 | ||
Oxidative stress and diabetic retinopathy | Q35819297 | ||
The polyol pathway as a mechanism for diabetic retinopathy: attractive, elusive, and resilient | Q37068700 | ||
Glycemic variability: the third component of the dysglycemia in diabetes. Is it important? How to measure it? | Q37404282 | ||
Primary and secondary coenzyme Q10 deficiency: the role of therapeutic supplementation. | Q38085720 | ||
Prevalence of and risk factors for diabetic retinopathy in Koreans with type II diabetes: baseline characteristics of Seoul Metropolitan City-Diabetes Prevention Program (SMC-DPP) participants | Q39991729 | ||
A randomized clinical trial of coenzyme Q10 and GPI-1485 in early Parkinson disease | Q40254829 | ||
Role of inflammation in the pathogenesis of diabetic retinopathy | Q41012127 | ||
Total antioxidant status and coronary artery calcification in type 1 diabetes | Q43720027 | ||
Specific markers of lipid peroxidation issued from n-3 and n-6 fatty acids | Q44745994 | ||
Retinal ganglion cells in model organisms: development, function and disease | Q46365457 | ||
Total antioxidant capacity and levels of epidermal growth factor and nitric oxide in blood and saliva of insulin-dependent diabetic patients | Q46540402 | ||
Markers of innate immune activity in patients with type 1 and type 2 diabetes mellitus and the effect of the anti-oxidant coenzyme Q10 on inflammatory activity | Q46924121 | ||
The effect of ubiquinone in diabetic polyneuropathy: a randomized double-blind placebo-controlled study. | Q49188414 | ||
P433 | issue | 4 | |
P921 | main subject | diabetic retinopathy | Q631361 |
P304 | page(s) | 155-163 | |
P577 | publication date | 2015-08-31 | |
P1433 | published in | Redox Report | Q15758836 |
P1476 | title | The effect of ubiquinone and combined antioxidant therapy on oxidative stress markers in non-proliferative diabetic retinopathy: A phase IIa, randomized, double-blind, and placebo-controlled study. | |
P478 | volume | 21 |
Q91640915 | Adjuvant Therapies in Diabetic Retinopathy as an Early Approach to Delay Its Progression: The Importance of Oxidative Stress and Inflammation |
Q90070032 | Oxidative Stress as the Main Target in Diabetic Retinopathy Pathophysiology |
Q47235697 | Targeting oxidative stress through antioxidants in diabetes mellitus |
Q92136172 | The impact of coenzyme Q10 on metabolic and cardiovascular disease profiles in diabetic patients: A systematic review and meta-analysis of randomized controlled trials |
Q92120247 | Therapeutic effect of lutein supplement on non-proliferative diabetic retinopathy: A retrospective study |
Q50049076 | Therapeutic targets for altering mitochondrial dysfunction associated with diabetic retinopathy |
Search more.